Phase I Human Analytics (HALO) Study (NCT05423860)
This is a Human Analytics Longitudinal Observational (HALO) Study. A Phase I Study to Analyze All Available Biomarkers and Determinants of Health to Increase Diagnostic Accuracy While Reducing the Time to Diagnosis of Disease.
๐ฉบ Plain-English Summary (8th-Grade Level)
Discover, optimize, standardize, and validate clinical-trial measures and biomarkers used to diagnose and differentiate cardiovascular, oncologic, neurologic, and other diseases and disorders. Specifically, our research study endeavors to improve disease and disorder diagnosis to the earliest clinical states, in preclinical states, and to develop ensemble multivariate biomarker risk scores leading to cardiovascular, oncologic, neurologic, and other diseases and disorders. Additionally, the study aims to: * Evaluate data analysis techniques to improve diagnostic accuracy and reduce time to diagnosis. * Evaluate data analysis techniques to improve risk stratification for participants through machine learning algorithms. * Direct participants to relevant and applicable clinical trials.
Who can join: Review the eligibility criteria below.
Location: Desert Medical Imaging โ Indian Wells, California
Age range: 45 Years to 90 Years
๐งช Interventions in This Study
- no interventions will be performed (observational) (OTHER)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Desert Medical Imaging โ Indian Wells, California
๐ Contact the Study Coordinator
Phone: (760) 776-8989
Email: chris.hancock@halodx.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cardiovascular Diseases
- The Jackson Heart Study of Cardiovascular Disease Among African Americans โ Jackson, Mississippi
- Using Big Data to Conduct Innovative Cardiovascular Clinical Trials โ Toronto, Ontario
- Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study โ Ottawa, Ontario
- Response of Cardiometabolic Biomarkers and Gut Microbiota to Walnut Consumption โ Davis, California
- Black Women's Life Experience On Cardiovascular Health Via Ongoing Monitoring โ Arlington, Texas
- Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT) โ Baltimore, Maryland
Explore by condition: All Cardiovascular Diseases clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.